Posts Tagged ‘Maine’

Three Strikes and They’re Out?

Thursday, August 12th, 2010

Last Wednesday patients and doctors welcomed a third win in the courts upholding state laws that limit pharmaceutical company interference with good prescribing. Judge Lynch on the U.S. Court of Appeals in Boston (First Circuit) handed down the ruling on Maine’s 2007 “data mining” law banning the use or sale of records showing which drugs health care practitioners have prescribed to their patients. The Maine law is nearly identical to laws in New Hampshire and Vermont that have also survived challenges by industry.

Prescription data mining, described in more detail here, is the business of health information organizations, such as IMS Health, Verispan and Wolters Kluwer. These companies purchase records from pharmacies containing prescription information (but not patient identities), combine them with practitioner profiles purchased from the American Medical Association and sell complete practitioner prescribing profiles to pharmaceutical companies. These profiles let marketers know exactly which drugs individual practitioners are prescribing so they can tailor their promotional messages to them. Maine’s law allows health care practitioners to “opt-out” of releasing their prescribing data for marketing purposes at each instance of licensure or re-licensure. The AMA has its own “opt-out” system, but few doctors even know about the program. Furthermore, it still allows drug companies to buy the disapproving physician’s prescribing profile, only requiring they refrain from sharing the individual-level prescribing data directly with the sales reps.

It’s clear that showing up in an office to pitch a new drug armed with the doctor’s complete prescribing history creates an unlevel playing field, making the interaction less about education and more about sales objectives. It’s not a surprise that most prescribers are not aware that their prescribing data is for sale. It’s even less surprising that drug reps are reluctant to inform prescribers that they have access to this information.

Solutions and Appeals

In 2006, New Hampshire passed the first-in-the-nation law completely banning the sale and use of prescriber-identifiable prescription data for marketing purposes. Representative Cindy Rosenwald—whom we’ve interviewed on related privacy issues before—pushed the legislation through the state assembly in 2006 as a measure to bolster public health and curb rising drug costs due to industry marketing.

Health information companies challenged the New Hampshire law shortly after it was enacted. A U.S. district court in New Hampshire overturned the law in April 2007 on the grounds that the use of such data by health information companies, pharmacies, and drug companies constitutes commercial speech; the law, they asserted, restricted that speech. New Hampshire Attorney General Kelly Ayotte appealed the decision and took the case to the United States Court of Appeals for the First Circuit. Community Catalyst and other consumer, professional and medical organizations presented arguments supporting the law in an amicus brief filed by, Sean Flynn of American University’s Washington College of Law

Strike One:

In late 2008, the First Circuit solidified the first in a series of major wins for prescription privacy advocates, upholding the New Hampshire law and affirming its constitutionality.  The Court found that the law regulates conduct rather than speech, so does not infringe on First Amendment rights. It ruled that the state can regulate this practice since it affects public health and costs of care. Last year, the Supreme Court refused to hear a further appeal of the New Hampshire law filed by the plaintiffs (IMS and Verispan).

In 2007, Vermont legislators had passed a similar law banning the use of prescriber-identifiable data, except in cases where a health care practitioner “opts-in,” agreeing to release their prescribing records to marketers.

Strike Two:

The Federal District Court in Vermont upheld the law on grounds that it would protect public health and contain drug costs, but the ruling was again appealed by health information organizations. Shortly after the Supreme Court refused to hear an appeal of the New Hampshire law, the Court of Appeals for the Second Circuit denied a request to grant an injunction of Vermont’s law, allowing the law to go into effect last July. We and others supported the law in an amicus brief. The Court is still considering the appeal and a decision is expected soon.

Where We Stand

For those keeping score, we now have three variations of data mining laws in three states. We’ve got the total ban, the “opt-in” and the “opt-out.” Each of the states has also been given the go-ahead to implement its law, though we’re still waiting for the outcome of the final appeal on the Vermont statute.

The First Circuit ruling is another win for prescription privacy and public health advocates. But the ruling may be most significant because there isn’t really anything remarkable about it. It feels like we’ve been here before, heard many of the same arguments and had similar results. Even though these three laws differ slightly in how they go about it, they all have the same intent: to limit drug reps’ access to prescriber-identifiable data. The legal and public health arguments for limiting data mining are clear, and that’s been shown time and again. Last week’s ruling in Maine cited many of the same findings from Vermont and New Hampshire decisions: the statute is constitutional, does not infringe on free speech guarantees, stands to protect public health and will save public dollars.

Maybe this was strike three. Or maybe the final appeals court ruling on Vermont’s law will be strike three. Sooner or later it will come and advocates can focus on developing programs and systems that use prescription information to improve patient care, rather than simply defending against its use for marketing practices that drive up costs. With the passage of the new health law, we need smart strategies like these to make the health care system more sustainable while improving quality.

– Ian Reynolds, program associate

The Insider: Implementation Nation

Tuesday, April 20th, 2010

Although the national media spotlight has moved on, the work of health care reform is only beginning. Today we  look at some of the recent developments in Massachusetts—which is sort of a health reform “beta site”—and what they tell us about reform in the rest of the country. We’ll also examine one of the early implementation provisions: the temporary high-risk pool.

Massachusetts: The gift that keeps on giving

Throughout the debate on national health care reform, Massachusetts has played an outsized role. The bipartisan nature and popularity of reform in the state, its success at reducing the number of uninsured, and the prominent role Massachusetts pols from both parties played in the national reform saga have all helped to make what happens in the Bay State unusually significant. This is likely to continue to be true going forward.

Because Massachusetts is farther down the implementation path, it has already encountered issues that will come up in other places. Three recent developments in Massachusetts highlight the state’s continuing relevance to the reform debate.

The first is the controversy over insurance premium rate hikes.  Earlier this spring, the Massachusetts Division of Insurance denied dozens of premium rate increases as being excessive. (See the Boston Globe article.) The ruling led to a court challenge by insurers and a brief insurance “strike” as Massachusetts insurers took their plans off the market.  (Since the court refused to grant the insurers a preliminary injunction most plans are again available). Although this preliminary ruling went against the insurers, there is no guarantee about the final outcome.

The takeaway? Insurers will play hardball to resist downward pressure on premiums. States need strong tools and political will to fight back. An effort to beef up premium oversight had to be stripped from the final national health reform bill because it did not fit within the rules of the budget reconciliation process, but a stand-alone rate regulation bill is being championed by Sen. Diane Feinstein. A hearing is scheduled for this Tuesday in the HELP committee, but odds of passage are uncertain, since it’s likely that Republicans will present a united front in opposition, making it hard to get the necessary 60 votes.  In the absence of federal authority,  advocates may want to turn their attention to strengthening state oversight.

A second issue to hit the Boston media recently also has lessons for national reform. Insurers allege that there is a group of people taking advantage of continuous open enrollment to purchase non-group insurance for a short period of time, schedule costly medical care, and then drop out. Like so much of national reform, this claim comes with a heavy dose of politics attached, since the charges are being made by a former insurance industry exec who’s running for governor.

These “short-stayer” allegations have yet to be substantiated. So far insurers have not provided data which shows what medical care alleged short-stayers are using, whether or where they were previously insured, and whether the problem is growing or actually diminishing. The Division of Insurance is studying the issue and its report is expected soon.

Meanwhile, we can and should expect insurers to fight to undermine the impact of guaranteed issue by narrowing access to insurance. This battle will be fought first at the federal level as HHS determines the initial and subsequent enrollment periods, and it’s critical that consumers push back to make sure that insurance remains as accessible as possible.

The third implementation issue in Massachusetts with implications for the states is one that has received no media attention (and was not heeded by federal lawmakers during the debate): When it comes to helping people make informed choices among competing insurance plans, standardizing actuarial values is simply not enough.

Within any given benefit tier (gold, silver, etc.), insurers can vary cost-sharing arrangements so much that comparison remains difficult. Focus groups in Massachusetts show what those done by national organizations do: What people want is better choices, not an infinite number of choices. And so after several years of experimenting with actuarial value, the Massachusetts Connector has moved to standardize benefits. Federal law does not require states to create standard benefits, but it does not prohibit it, either. Nor is there any reason that standardization has to wait for the 2014 kick-off of health insurance exchanges.  Advocates should consider pushing for greater standardization in their state markets now.

High-Risk Pool rules present states with tough decisions

One of the first provisions of national health care reform slated to be implemented (90 days after passage) is the creation of a temporary high-risk pool (HRP) for those excluded from coverage due to a pre-existing condition. As welcome as this new program is, given that most existing state high risk pools perform poorly, it may prove difficult to effectively integrate the new program with existing state law.

PPACA establishes a set of rules for both the federal HRP and any existing state pool that wants to tap into the $5 billion in federal support made available by health reform.  These rules include setting a minimum actuarial value and out-of-pocket maximum for HRP coverage. They also prohibit the imposition of pre-existing condition exclusions, require rates to be the same in the HRP as in the market generally, and set a limit on age rating of no more than 4-1. All of these are welcome changes.

However–and it’s a big however–federal law also restricts eligibility for the HRP to those who have been uninsured for at least six months. While this provision is designed to prevent people from dropping existing coverage to enroll in the federal plan and to help stretch federal dollars, it also creates some problems. Consider these four types of states:

States with no HRP and no guaranteed access to insurance in the non-group market–For these states there is no problem: Either the state will set up an HRP that meets federal standards, or the federal government will set up a pool on behalf of the residents of that state. End of story.

States with an HRP that is worse in all respects to the federal lawA state could “true up” its program to meet federal requirements, or it could do nothing, in which case the federal government would set up a parallel program.

What happens then? Everyone with a pre-existing condition (who can afford the premiums) can enroll in the federal program except those who are already enrolled in the state HRP. They either have to take the risk of going without coverage for six months, or remain locked into inferior and costlier coverage in the state pool.

States with an HRP that does not require a six-month wait
–Even if a state pool is as good as or better than the federal requirements in most respects, the requirement for a six-month waiting period could create problems.

In general, states can run a program that is better than the federal program if they choose. But, if states do not impose a six-month waiting period, their program will not qualify for federal assistance.So they have the choice:   either impose a new access restriction on people with pre-existing conditions, or set up a parallel pool (or allow the federal government to). In the latter case, those who can take a chance on going without coverage for six months could join the federal pool, while those who could not would retain or join the state pool, leading to a generally sicker pool of enrollees in the state pool.

States that already have guaranteed issue and modified community rating in their non-group market–A number of states, including New York, Maine, Vermont and several others have already eliminated pre-existing condition exclusions instead of having a high risk pool. However, because of the six-month no-coverage requirement it’s unclear if these states would benefit at all.

Regulations for how states should implement the HRP provisions are expected very soon from HHS, but it’s unclear whether the Secretary has the authority to address these problems, or if the solution requires a Congressional fix.

Coming next time: Repeal Watch!

–Michael Miller, director of strategic policy

America needs better care!

Tuesday, April 13th, 2010

cbcHealth reform is law. The hard work of fixing our health system begins now. That’s the message of  Campaign for Better Care, a recently-launched effort to improve health care coordination and quality for people across the country. (Here’s the ad (pdf) that ran in Politico.)

The Campaign, a joint effort of the National Partnership for Women & Families, Community Catalyst and the National Health Law Program (NHeLP), is working to ensure that we realize the promise of health reform by improving health care quality, coordination and communication for older patients with multiple health problems and their family caregivers.

A newly released national survey of Americans 50+ tells the story.

  • Something to talk about. Nearly three-quarters have wished that their doctors would talk and share information with each other.
  • People who take the most meds need to hear more about medication interactions from their doctor. Forty percent of people who take five or more medications say their doctors do not talk to them about potential interactions with other drugs or over-the-counter medications when prescribing new medications.
  • Different info from different doctors. More than one third of people who use the health care system most say they’ve received conflicting information from different doctors.
  • Taking the test over—and not because they failed. One in eight (13 percent) has had to redo a test or procedure because the doctor or hospital did not have the earlier results.
  • Do you have any questions? Yes. Three-quarters of those who use the health care system most have left a doctor’s office or hospital confused about what to do at home.

But the real story is told by people like Joann, whose life was turned upside down last summer when her 79-year-old mother fell and broke her hip. Because her mother also suffers from osteoporosis and dementia, Joann stayed overnight in the hospital for two weeks to help her navigate the system.  She was physically and emotionally exhausted in this solo effort to make sure her mother was safe and well-cared for once she returned home from the hospital.

The new health reform bill is full of programs that could help people like Joann and her mother by providing the comprehensive, coordinated, patient-centered care they need.  And, the Campaign is committed to taking the essential next step: ensuring that these programs are designed and implemented with the needs of patients and their family caregivers front and center.  Because if we can make the system work for people with the most challenging health care needs, we can make it work for everyone.

To support the national Campaign, Community Catalyst is also working in six states to build support for these kind of programs:

Maine (Consumers for Affordable Health Care)

Massachusetts (Health Care for All)

Ohio (UHCAN Ohio)

North Carolina (NC Justice Center)

Pennsylvania (Consumer Health Coalition)

Wisconsin (Coalition of WI Aging Groups)

Check out the state campaign websites to learn more about what they’re doing to promote better care in their states.  And be sure to visit the national campaign website www.CampaignforBetterCare.org to learn more about the campaign and how to get involved.

-Renee Markus Hodin, project director